Skip Nav Destination
1-11 of 11
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
A Phase 1 Dose-Escalation Study of Adding Venetoclax to a Reduced Intensity Conditioning (RIC) Regimen Prior to Allogeneic Hematopoietic Cell Transplantation for Patients with High Risk Myeloid Malignancies
Jacqueline S Garcia, MD, Haesook T. Kim, PhD, Jennifer Brock, Amy Han, MPH, Jeremy A. Ryan, SM, Thelma Mashaka, BA, Anthony G. Letai, MD PhD, R. Coleman Lindsley, MD PhD, Mahasweta Gooptu, MD, Vincent T. Ho, MD, John Koreth, MBBS, DPhil, Sarah Nikiforow, MD PhD, Rizwan Romee, MD PhD, Ilene Galinsky, Martha Wadleigh, MD, David P. Steensma, MD, Richard M. Stone, MD, Robert J. Soiffer, MD, Corey Cutler, MD MPH, FRCPC, Daniel J. DeAngelo, MD, Joseph H. Antin, MD
Blood (2019) 134 (Supplement_1): 258.
Targeted inhibition of PI3Kα/δ is synergistic with BCL-2 blockade in genetically defined subtypes of DLBCL
Kamil Bojarczuk, Kirsty Wienand, Jeremy A. Ryan, Linfeng Chen, Mariana Villalobos-Ortiz, Elisa Mandato, Joanna Stachura, Anthony Letai, Lee N. Lawton, Bjoern Chapuy, Margaret A. Shipp
Blood (2019) 133 (1): 70–80.
Includes: Supplemental data
Nathalie A Johnson, MD PhD, Claudia M Wever, PhD, Dominique Geoffrion, BSc, Ghassemian Artin, MD, Brailovski Eugene, Pierre Sesques, MD, Jeremy A. Ryan, SM, Liliana Stoica, Josee Hebert, MD, Tina Petrogiannis-Haliotis, MD PhD, Svetlana Dmitrienko, MD PhD, Frenkiel Saul, MD, German Ott, MD, Annette Staiger, Christian Steidl, MD, David W. Scott, PhD MD, FRACP, FRCPA, Koren Kathleen Mann, PhD, Anthony Letai, MD PhD
Blood (2018) 132 (Supplement 1): 4126.
Targeted Inhibition of PI3K α/δ Is Synergistic with BCL-2 Blockade in Genetically Defined Subtypes of DLBCL
Kamil Bojarczuk, PhD, Kirsty Wienand, PhD, Jeremy A. Ryan, SM, Linfeng Chen, PhD, Mariana Villalobos-Ortiz, Elisa Mandato, PhD, Joanna Stachura, MSc, Lee N. Lawton, PhD, Anthony Letai, MD PhD, Bjoern Chapuy, MDPhD, Margaret A. Shipp, MD
Blood (2018) 132 (Supplement 1): 39.
Altered cellular dynamics and endosteal location of aged early hematopoietic progenitor cells revealed by time-lapse intravital imaging in long bones
Anja Köhler, Vince Schmithorst, Marie-Dominique Filippi, Marnie A. Ryan, Deidre Daria, Matthias Gunzer, Hartmut Geiger
Blood (2009) 114 (2): 290–298.
Includes: Multimedia, Supplemental data
Wei Liu, MD, MS, Lei Wang, PhD, Xun Shang, PhD, Fukun Guo, PhD, Marnie A. Ryan, PhD, Hartmut Geiger, PhD, Yi Zheng, PhD
Blood (2008) 112 (11): 68.
Intravital Imaging of Young and Aged Stem Cells in the Marrow of Long Bones: Visualizing Mammalian Stem Cell Behavior in Real-Time in Vivo
Anja Köhler, Vince Schmithorst, Marie-Dominique Filippi, PhD, Marnie A. Ryan, PhD, Deidre Daria, Matthias Gunzer, Hartmut Geiger, PhD
Blood (2008) 112 (11): 2418.
Pharmacological Inhibition of EGFR Signaling Enhances G-CSF Induced Hematopoietic Stem Cell Mobilization.
Marnie A. Ryan, PhD, Ellen Xing, David Schleimer, Kalpana Nattamai, Deidre Daria, Wei Liu, MD, MS, Michael Jansen, MS, PhD, Nancy Ratner, Timothy Le Cras, Gary Van Zant, PhD, Yi Zheng, PhD, Hartmut Geiger, PhD
Blood (2008) 112 (11): 2337.
Positional Cloning: Regulation of Hematopoietic Stem and Progenitor Cell Mobilization through EGF Receptor Signaling.
Marnie A. Ryan, PhD, David Schleimer, BS, Kalpana Nattamai, BS, Deidre Daria, BS, Timothy Le Cras, PhD, Nancy Ratner, PhD, Hartmut Geiger, PhD
Blood (2007) 110 (11): 1252.
Zhenlan Xing, Marnie A. Ryan, Deidre Daria, Kalpana J. Nattamai, Gary Van Zant, Lei Wang, Yi Zheng, Hartmut Geiger
Blood (2006) 108 (7): 2190–2197.
Identification of a cell-surface antigen associated with activated T lymphoblasts and activated platelets
Blood (1991) 77 (1): 84–93.